Judit Marsillach Selected Research

Aryldialkylphosphatase (Paraoxonase)

1/2022	Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis.
2/2021	Paraoxonase-1 and -3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer's Disease.
6/2019	Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.
1/2014	Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI Exome Sequencing Project.
12/2013	Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome.
8/2013	Paraoxonase-1 is associated with corneal endothelial cell alterations in patients with chronic obstructive pulmonary disease.
5/2013	Paraoxonase-1 status in patients with hereditary hemochromatosis.
4/2013	Paraoxonase-1 deficiency is associated with severe liver steatosis in mice fed a high-fat high-cholesterol diet: a metabolomic approach.
1/2012	Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: results from the PREDICT study.
8/2011	Paraoxonase-1 is only present in traceable amounts in seminal fluid and does not show any relationship with male subfertility.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Judit Marsillach Research Topics

Disease

11	Inflammation (Inflammations) 02/2021 - 12/2005
8	Atherosclerosis 01/2021 - 12/2007
7	Liver Diseases (Liver Disease) 05/2010 - 12/2005
4	Alzheimer Disease (Alzheimer's Disease) 02/2021 - 06/2019
4	Fatty Liver 04/2013 - 02/2006
3	HIV Infections (HIV Infection) 01/2012 - 09/2007
3	Fibrosis (Cirrhosis) 01/2009 - 07/2006
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2021 - 06/2019
2	Insulin Resistance 12/2013 - 01/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2013 - 12/2009
2	Arteriosclerosis 02/2010 - 02/2006
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2008 - 07/2006
2	Lymphoma (Lymphomas) 01/2008 - 01/2008
2	B-Cell Leukemia (Leukemia, B Cell) 01/2008 - 01/2008
2	Infections 09/2007 - 11/2005
2	Chronic Hepatitis (Chronic Active Hepatitis) 07/2006 - 11/2005
1	Diabetes Mellitus 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Pregnancy Complications 01/2021
1	Atherosclerotic Plaque (Atheroma) 05/2015
1	Autoimmune Diseases (Autoimmune Disease) 05/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2015
1	Ischemic Stroke 01/2014
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2014
1	Stroke (Strokes) 01/2014
1	Pediatric Obesity 12/2013
1	Cataract (Cataracts) 08/2013
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2013
1	Hemochromatosis (Bronze Diabetes) 05/2013
1	Type 2 Diabetes Mellitus (MODY) 01/2012
1	Male Infertility (Male Sterility) 08/2011
1	Female Infertility 08/2010
1	Pancreatitis 05/2008
1	Body Weight (Weight, Body) 12/2007
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 06/2007
1	Chronic Renal Insufficiency 04/2007
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2007
1	Homocysteinemia 04/2006
1	Pre-Eclampsia (Preeclampsia) 01/2006
1	Virus Diseases (Viral Diseases) 11/2005
1	Chronic Hepatitis C 11/2005

Drug/Important Bio-Agent (IBA)

21	Aryldialkylphosphatase (Paraoxonase)IBA 01/2022 - 11/2005
8	Proteins (Proteins, Gene)FDA Link 02/2021 - 05/2010
5	LipidsIBA 02/2021 - 05/2008
5	EnzymesIBA 01/2014 - 07/2006
4	AntioxidantsIBA 01/2021 - 11/2005
3	HDL LipoproteinsIBA 02/2021 - 09/2007
3	Lipoproteins (Lipoprotein)IBA 01/2021 - 01/2012
3	CholesterolIBA 04/2013 - 02/2006
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2010 - 12/2005
2	ProteomeIBA 01/2021 - 12/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2009
2	HDL CholesterolIBA 12/2020 - 02/2010
2	IronIBA 05/2013 - 04/2007
2	Triglycerides (Triacylglycerol)IBA 01/2012 - 02/2010
2	ChemokinesIBA 09/2010 - 12/2005
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2010 - 09/2007
2	oxidized low density lipoproteinIBA 12/2009 - 04/2007
2	Dietary CholesterolIBA 12/2009 - 12/2007
2	LDL Lipoproteins (beta Lipoproteins)IBA 09/2007 - 04/2007
2	PeroxidesIBA 07/2006 - 11/2005
1	arylesteraseIBA 01/2022
1	Biological ProductsIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 06/2019
1	Peptides (Polypeptides)IBA 06/2019
1	CreatinineIBA 01/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012
1	HydrolasesIBA 12/2009
1	Messenger RNA (mRNA)IBA 12/2009
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 12/2009
1	PPAR deltaIBA 01/2009
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2009
1	Taurocholic Acid (Sodium Taurocholate)IBA 05/2008
1	Tissue Inhibitor of Metalloproteinase-3IBA 01/2008
1	ProcollagenIBA 01/2008
1	Metalloproteases (Metalloproteinases)IBA 01/2008
1	Matrix Metalloproteinases (MMPs)IBA 01/2008
1	Procollagen Type IIBA 01/2008
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2008
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2008
1	Glucose (Dextrose)FDA LinkGeneric 12/2007
1	AntibodiesIBA 04/2007
1	Erythropoietin FDA Link 04/2007
1	Lipid PeroxidesIBA 07/2006
1	ApolipoproteinsIBA 02/2006
1	Transcription Factors (Transcription Factor)IBA 02/2006
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2006
1	C-Reactive ProteinIBA 12/2005
1	Protein Isoforms (Isoforms)IBA 11/2005
1	Free RadicalsIBA 11/2005

Therapy/Procedure

1	Aftercare (After-Treatment) 02/2010